Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: Patterns of failure, late toxicity and second malignancies

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 3, 1997, Pages 609-616

  Vlachaki, Maria T ^a   Ha, Chul S ^a   Hagemeister, Frederick B ^a   Fuller, Lillian M ^a   Rodriguez, Maria A ^a   Besa, Pelayo C ^a   Hess, Mark A ^a   Brown, Barry ^a   Cabanillas, Fernando ^a   Cox, James D ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UTMDACC   (United States)

Author keywords

Failure patterns; Hodgkin's disease; Irradiation; Late toxicity

Indexed keywords

CHLORMETHINE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; IRRADIATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RADIATION INJURY; RETROSPECTIVE STUDY; SECOND CANCER; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030963961     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00371-4     Document Type: Article

References (42)

1. Biti, G. P.; Cimino, G.; Cartoni, C.; Magrini, S. M.; Anselmo, A. P.; Enrici, R. M.; Bellesi, G. P.; Bosi, A.; Papa, G.; Giannarelli, D.; et al. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: Eight year update of an Italian prospectiverandomized study. J. Clin. Oncol. 10:1367-1369; 1992.
2. Biti, G.; Cellai, E.; Magrini, S. M.; Papi, M. G.; Ponticelli, P.; Boddi, V. Second solid tumors and leukemia after treatment for Hodgkin's disease: An analysis of 1121 patients from a single institution. Int J. Radiat. Oncol. Biol. Phys. 29:25-31; 1994.
3. Boivin, J. F.; Hutchinson, G. B.; Lubin, J. H.; Mauch, P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69:1241-1247; 1992.
4. Carbone, P. P.; Kaplan, H. S.; Musshoff, K.; Smithers, D. W.; Tubiana, M. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 31:1860-1861; 1971.
5. Cimino, G.; Biti, G. P.; Cartoni, C.; Magrini, S. M. Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: Evidence of a more difficult rescue for patients relapsed after chemotherapy. Eur. J. Cancer. 28A:1853-5; 1992.
6. Cosset, J. M.; Henry-Amar, M.; Meerwaldt, J. H.; Carde, P.; Noordijk, E. M.; Thomas, J.; Burgers, J. M. V.; Somers, R.; Hayat, M.; Tubiana, M.; (on behalf of the EORTC Lymphoma Cooperative Group). The EORTC trials for limited stage Hodgkin's disease. Eur. J. Cancer 28A:1847-1850; 1992.
7. Cosset, J. M.; Henry-Amar, M.; Pellae-Cosset, B.; et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int. J. Radiat. Oncol. Biol. Phys. 21:447-449; 1991.
8. Cox, J. D. Lymphomas and leukemia. In: Cox, J. D., ed. Moss' radiation oncology: rationale, technique, results. St. Louis, MO: Mosby-Year Book, Inc.; 1994:795-826.
9. Cox, J. D.; Stetz, J.; Pajak, T. F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 31:1341-1346; 1995.
10. Cox, J. D.; Stoffel, T. J. Clinical versus pathologic stage I and II Hodgkin's disease. Oncology 37:325-328; 1980.
11. Crhkovich, M. J.; Leopold, K.; Hoppe, R. T.; Mauch, P. Stage I to IIB Hodgkin's disease: The combined experience at Stanford University and the Joint Center for Radiation Therapy. J. Clin. Oncol. 5:1041-1049; 1987.
12. Dubray, B.; Henry-Amar, M.; Meerwaldt, J. H.; Noordijk, E. M.; Dixon, D. O.; Cosset, J. M.; Thames, H. D. Radiation induced lung damage after thoracic irradiation for Hodgkin's disease: The role of fractionation. Radiother. Oncol. 36:211-217; 1995
13. Ganesan, T. S.; Wrigley, P. F. M.; Murray, P. A.; Stansfeld, A. G.; d'Ardenne, A. J.; Arnott, S.; Jones, A.; Shand, W. S.; Malpas, J. S.; Lister, T. A Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital. Br. J. Cancer 62:314-318; 1990.
14. Gospodarowicz, M. K.; Sutcliffe, S. B.; Bergsagel, D. E.; et al. Radiation therapy in clinical stage I and II Hodgkin's disease. Eur. J. Cancer 28A:1841-1846; 1992.
15. Gospodarowicz, M. K.; Sutcliffe, S. B.; Clark, R. M.; Dembo, A. J.; Fitzpatrick, P. J.; Munro, A. J.; Bergasel, D. E.; Patterson, B. J.; Tsang, R.; Chua, T. et al. Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int. J. Radiat. Oncol. Biol. Phys. 22:859-865; 1992.
16. Hagemeister, F. B.; Fuller, L. M.; Velasquez, W. S.; Sullivan, J. A.; North, L.; Butler, J. J.; Johnston, D. A.; Shullenberger, C. C. Involved field radiotherapy versus extended field radiotherapy versus involved field radiotherapy followed by six cycles of MOPP. Cancer Treat. 66:789-798; 1982.
17. Hancock, S. L.; Tucker, M. A.; Hoppe, R. T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270:1949-1955; 1993.
18. Hancock, S. L.; Hoppe, R. T.; Horning, S. J.; Resenberg S. A. Intercurrent death after Hodgkin's disease therapy in radiotherapy and adjuvant MOPP trials. Ann. Intern. Med. 109: 183-189; 1988.
19. Hellman, S.; Mauch, P. Role of radiation therapy in the treatment of Hodgkin's disease. Cancer Treat. Rep. 66:915-925; 1982.
20. Henry-Amar, M.; Hayat, M.; Meerwaldt, J. H.; Burgers, J. M. V.; Carde, P.; Somers, R.; Noordijk, E. M.; Monconduit, M.; Thomas, J.; Cosset, J. M.; et al. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. Int J. Radiat. Oncol. Biol. Phys. 19;1155-1157; 1990.
21. Herman, T. S.; Hoppe, R. T.; Donaldson, S. S.; Cox, R. S.; Rosenberg, S. A.; Kaplan, H. S. Late relapses among patients treated for Hodgkin's disease. Ann. Intern. Med. 102:292-297; 1985.
22. Hoppe, R. T.; Hanlon, A. L.; Hanks, G. E.; Owen, J. B. Progress in the treatment of Hodgkin's disease in the United States. The Patterns of Care Study. Cancer 74:3198-3203; 1994.
23. Hoppe, R. T.; Coleman, C. N.; Cox, R. S.; Rosenberg, S.; Kaplan, H. S. The management of stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: The Stanford experience. Blood 59:455-465; 1982.
24. Hoppe, R. T.; Horning, S. J.; Rosenberg, S. A. The concept, evolution and preliminary results of the current Stanford clinical trials for Hodgkin's disease. Cancer Surveys 4:459-475; 1985.
25. Horning, S. J., Hoppe, R. T.; Kaplan, H. S.; et al. Female reproductive potential after treatment for Hodgkin's disease. N. Engl. J. Med. 304:1377-1382; 1981.
26. Johnson, D. W.; Hoppe, R. T.; Cox, R. S.; Rosenberg, S. A.; Kaplan, H. S. Hodgkin's disease limited to intrathoracic sites. Cancer 52:8-13; 1983.
27. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
28. Leibenhaut, M. H.; Hoppe, R. T.; Efron, B. et al. Prognostic indicators at laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J. Clin. Oncol. 7:81-91; 1989.
29. Leslie, N. T.; Mauch, P. M.; Hellman, S. Stage IA to IIB supradiaphragmatic Hodgkin's disease, long-term survival and relapse frequency. Cancer 55:2072-2078; 1985.
30. Levitt, S. H.; Lee, C. K. K.; Aeppli, D.; Lindgren, B.; Peterson, B. A. The role of radiation therapy in Hodgkin disease: Experience and controversy. Cancer 70:693-703; 1992.
31. Levitt, S. H.; Lee, C. K. K. Aeppli, D. M.; et al. Radical treatment of Hodgkin's disease with radiation therapy: Results of a 15-year clinical trial (the 1985 Erskine Lecture). Radiology 162:623-630; 1987.
32. Longo, D. L.; Glatstein, E.; Duffey, P. L.; et al. Radiation therapy versus combination chemotherapy in the treatment of early stage Hodgkin's disease: Seven-year results of a prospective randomized trial. J. Clin. Oncol. 9:906-917; 1991.
33. Mauch, P. M.; Canellos, G. P.; Shulman, L. N.; Silver, B.; Tarbell, N. J.; Come, S.; Rabin, M. S.; Coleman, C. N. Mantle irradiation alone for selected patients with laparotomy staged IA to IIA Hodgkin's disease: Preliminary results of a Prospective Trial. J. Clin. Oncol. 13:947-952; 1995.
34. Mendenhall, N. P.; Cantor, A. B.; Barre, D. M.; Lynch, J. W., Jr.; Million, R. R. The role of prognostic factors in treatment for early-stage Hodgkin's disease. Am. J. Clin. Oncol. 17: 189-195; 1994.
35. Mendenhall, N. P.; Shuster, J. J.; Million, R. R. The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease. Radiother Oncol. 14:219-229; 1989.
36. Noordijk, E. M.; Carde, P.; Mandard, A. M.; Mellink, W. A. M.; Monconduit, M.; Eghbali, H.; Tirelli, J.; Thomas, J.; Somers, R.; Dupouy, N.; Henry-Amar, M. Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early stage Hodgkin's disease. Ann. Oncol. 5:S107-S112; 1994.
37. Rodriguez, M. A.; Fuller, L. M.; Zimmerman, S. O.; Allen. P. K. Brown, B. W.; Munsell, M. F.; Hagemeister, F. B.; McLaughlin, P.; Velasquez, W. S.; Swan, F., Jr.; Cabanillas. F. F. Hodgkin's disease: Study of treatment of intensities and incidents of second malignancies. Ann. Oncol. 4:125-131: 1993.
38. Tubiana, M.; Henry-Amar, M.; Hayat, M.; Burgers, M.; Qasim, M.; Somers, R.; Sizoo, W.; Van der Schueren, E. The EORTC treatment of early stages of Hodgkin's disease: The role of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 10:197-210; 1984.
39. Tubiana, M.; Henry-Amar, M.; Carde, P.; Burgers, J. M. V. Hayat, M.; Van der Schueren, E.; Noordijk, E. M.; Tanguy A.; Meerwaldt, J. H.; Thomas, J.; De Pauw, B.; Monconduit. M.; Cosset, J. M.; Somers, R. Toward comprehensive management tailored to prognostic factors of patients with clinica stages I and II in Hodgkin's disease: The EORTC Lymphoma Group controlled clinical trials 1964-1987. Blood 73:47-56; 1989.
40. Tucker, M. A.; Coleman, C. N.; Cox, R. S., et al. Risk of second cancers after treatment for Hodgkin's disease. N. Engl. J. Med. 318:76-81; 1988.
41. Vijayakumar, S.; Myrianthopoulos, L. C. An updated dose response analysis in Hodgkin's Disease. Radiother. Oncol. 24:1-13; 1992.
42. Vlachaki, M. T.; Hagemeister, F. B.; Fuller, L. M.; Rodriguez, M. A.; Besa, P. C.; Hess, M. A.; Brown, B.; Cabanillas, F.; Cox, J. D. Long term outcome of treatment for Ann Arbor stage I Hodgkin's disease: Prognostic factors for survival and freedom from progression. Int. J. Radiat. Oncol. Biol. Phys. 38:593-599; 1997.